Efficacy of multimodal anticancer therapy in the course of pancreatic neuroendocrine carcinoma

Not required for Clinical Vignette.

書誌詳細
出版年:	Endokrynologia Polska
主要な著者:	Helena Zwinczewska, Marta Opalinska, Anna Sowa-Staszczak, Anna Kurzynska, Agnieszka Stefanska, Alicja Hubalewska-Dydejczyk
フォーマット:	論文
言語:	英語
出版事項:	Via Medica 2021-04-01
主題:	neuroendocrine tumours PRRT pNEC somatostatin analogue
オンライン･アクセス:	https://journals.viamedica.pl/endokrynologia_polska/article/view/72587

類似資料

Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours
著者:: Karolina Morawiec-Sławek, 等
出版事項: (2024-11-01)

Small Bowel Neuroendocrine Tumors—10-Year Experience of the Ottawa Hospital (TOH)
著者:: Abdulhameed Alfagih, 等
出版事項: (2023-08-01)

Clinical challenges and dilemmas in the management of advanced pancreatic neuroendocrine tumour — the first manifestation of von Hippel-Lindau disease in a young patient
著者:: Karolina Morawiec-Sławek, 等
出版事項: (2021-08-01)

Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
著者:: Katharina Wang, 等
出版事項: (2025-10-01)

Neuroendocrine Tumours: a Literature Review
著者:: K. V. Menshikov, 等
出版事項: (2021-05-01)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
著者:: Beata Kos-Kudła, 等
出版事項: (2017-06-01)

The Crystal Structure Elucidation of a Tetrapeptide Analog of Somatostatin DOTA-Phe-D-Trp-Lys-Thr-OMe
著者:: Sabina Diusenova, 等
出版事項: (2021-12-01)

Transcriptome of GH-producing pituitary neuroendocrine tumours and models are significantly affected by somatostatin analogues
著者:: Rihards Saksis, 等
出版事項: (2023-02-01)

Quantitative and qualitative assessment of a pituitary neuroendocrine tumor’s T2-signal intensity in acromegaly – a call for unification
著者:: Magdalena Godlewska-Nowak, 等
出版事項: (2024-11-01)

A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapy
著者:: Pei Zhang, 等
出版事項: (2025-10-01)

Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy
著者:: Fiona Ohlendorf, 等
出版事項: (2021-03-01)

Difficulties in the diagnosis and treatment of malignant paraganglioma of the urinary bladder
著者:: Ewelina Rzepka, 等
出版事項: (2020-04-01)

The Clinico-epidemiologic Characteristics of Iraqi Patients with Neuroendocrine Tumors and Their Response to Long Acting Octreotide
著者:: Marwah K. Abdulfattah, 等
出版事項: (2016-01-01)

Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor
著者:: Kieran J. Ved, 等
出版事項: (2024-03-01)

Combination Therapies with PRRT
著者:: Anna Yordanova, 等
出版事項: (2021-09-01)

Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours
著者:: Isuru Gamage, 等
出版事項: (2025-07-01)

Determination of neuron-specific enolase in patients with midgut-type tumour treated with somatostatin analogues
著者:: Paweł Gut, 等
出版事項: (2021-08-01)

Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
著者:: L. Yu. Morgunov
出版事項: (2015-06-01)

Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues
著者:: Manwar A. Mohammed AL-Naqqash
出版事項: (2016-01-01)

A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy
著者:: Daphne M. V. Huizing, 等
出版事項: (2020-06-01)

Emergency and routine presentation of neuroendocrine neoplasia in England: determinants of late presentation and survival outcomes
著者:: Marie Line El Asmar, 等
出版事項: (2025-04-01)

Sunitinib in pancreatic neuroendocrine tumors. Clinical case
著者:: A. A. Markovich, 等
出版事項: (2019-12-01)

Acromegaly and late-onset primary hyperparathyroidism in a female with a rare MEN1 gene variant of yet undetermined clinical significance (p.Val167Ala)
著者:: Magdalena Godlewska, 等
出版事項: (2020-12-01)

Oligosymptomatic neuroendocrine neoplasm of the small intestine with metastases spread to the heart, bones, muscles and intraperitoneally after a few years in remission – diagnostic and therapeutic challenges
著者:: Natalia Tyrybon, 等
出版事項: (2021-04-01)

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms
著者:: Maria Isabel del Olmo-Garcia, 等
出版事項: (2021-12-01)

Diagnostic imaging of gastrointestinal neuroendocrine neoplasms with a focus on ultrasound
著者:: Joanna Walczyk, 等
出版事項: (2019-09-01)

“Cold” Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy
著者:: Sara Massironi, 等
出版事項: (2025-02-01)

Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres
著者:: Gautham Nair, 等
出版事項: (2025-02-01)

Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy
著者:: Märta Persson, 等
出版事項: (2024-02-01)

Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel
著者:: Gema Marín Zafra, 等
出版事項: (2016-01-01)

The role of serotonin inhibition within the treatment of carcinoid syndrome
著者:: Joel George, 等
出版事項: (2023-06-01)

Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review
著者:: Anna La Salvia, 等
出版事項: (2021-10-01)

Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study
著者:: Nicoletta Ranallo, 等
出版事項: (2025-02-01)

Primary Neuroendocrine Tumor of the Testis and Osseous, Cardiac, and Lymph Node Metastases in a Young Patient
著者:: Matthias Penke
出版事項: (2014-12-01)

Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry
著者:: Attila Kollar, 等
出版事項: (2020-01-01)

Self-Administration of Long-Acting Somatostatin Analogues in NET Patients—Does It Affect the Clinical Outcome?
著者:: Anna Sowa-Staszczak, 等
出版事項: (2021-11-01)

Selection of the First <sup>99m</sup>Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation—Preclinical Assessment of Two Optimized Candidates
著者:: Melpomeni Fani, 等
出版事項: (2020-12-01)

Utility of Somatostatin Receptors in Gastrointestinal Tract and Pancreas Neuroendocrine Tumors
著者:: Kivilcim Eren ERDOGAN, 等
出版事項: (2020-12-01)

High-Grade Gastrointestinal Neuroendocrine Carcinomas: Multidisciplinary Approach Can Improve Survival Outcomes
著者:: Noorzia Syed, 等

Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy
著者:: Annie Mathew, 等
出版事項: (2025-04-01)